ERBB2 and cancer: Up to 20% of breast cancers are “triple negative” tumors (TNBC) as the three most common types of receptors known to fuel most breast cancer growth—estrogen, progesterone, and the receptor tyrosine‐protein kinase (HER‐2/neu) gene—are not present in cancer cells.